These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 6108897)

  • 1. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
    Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
    Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
    Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
    Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
    Li S; Feng H; Zhu J; Zhong C; Leng X; Du R
    Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of nifedipine on hepatic venous pressure gradient in patients with portal hypertension.
    Straumann A; Gyr K; Kiowski W; Bruendler H; Stalder GA
    Hepatogastroenterology; 1986 Jun; 33(3):101-4. PubMed ID: 3744280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
    Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
    Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
    Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
    Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
    Lotterer E; Wengert A; Fleig WE
    Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
    Barr JW; Lakin RC; Rösch J
    Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M; Toyonaga A; Tanikawa K
    Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
    Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
    Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
    Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
    Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
    Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
    Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.